Triton Market Research presents the Global Blood Plasma Market report segmented by Blood type (Immunoglobulins (Intravenous Immunoglobulins, Subcutaneous Immunoglobulins, Others), Coagulation Factor Concentrates, Albumin, Hyper Immunes, Other Plasma Fractionation Products), its Application (Immunology, Pulmonologist, Oncology, Rheumatology, Neurology, Hematology, Transplants, Others), by End-user (Hospitals & Clinics, Research Laboratories, Academic Institutions), by Geographical Region (North America, Europe, Asia Pacific and Rest of World), discussing Industry Value Chain Analysis, Porter's Five Force Analysis, Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2019-2027).
The fluid medium in which blood cells, platelets, nutrients, albumin, coagulation factors, protease inhibitors, immunoglobulins, etc. are suspended is known as plasma that mainly plays the role of an extracellular matrix, a carrier for nutrients and further augments flushing out of waste products from the body. Deficiency in any of the blood components can initiate a malady, which can result in accelerated growth for basic and targeted R&D industry. Also, the ongoing widespread acceptance of immunoglobulin-based therapies, exploration of new therapeutic ideas, boosting geriatric population, intensified prevalence of alpha-1 antitrypsin deficiency (AATD) and the increase in the patient pool for hemophilia treatment are mainly responsible for driving the market growth. Furthermore, blood plasma has proven to be an effective treatment plan. Henceforth, Triton Market Research report on the global blood plasma market depicts that the market will escalate at a compound annual growth rate of around 6.13% during the forecast period.
Immunoglobulins or Antibodies are glycoproteins produced by plasma cells specifically for immune response. Their deficiency in the blood plasma can result in recurring infections. Autoimmune diseases like Lupus, Rheumatoid Arthritis, Multiple sclerosis, etc. occur when the immunoglobulins attack its tissues. Recently, they have been in high demand for treating immunocompromised patients. Polyvalent antibodies have gained immense popularity for their requirement in recent years.
There are multitudes of opportunities in the Asia Pacific region for the blood plasma market. There are various organizations like the Asia-Pacific Blood Network ensure a cost-effective and safer supply of blood & its components throughout the region. The production of novel plasma therapies and the establishment of multiple plasma fractionation plants in the APAC region will be responsible for the rapid growth of the Asia Pacific blood plasma market in the global scenario.
The global blood plasma market has its leading companies like Adma Biologics Inc., Grifols International S.A., General Electric Co., Baxter International Inc., Octopharma AG, Cerus Corp., Biotest AG, Arthrex, CSL Ltd., China Biologic Products Inc. and Shire PLC are competing with each other to reap revenues and bolstering their market presence to the consumers.
The Global Wood Based Panel Market is estimated to witness growth with a CAGR of 6..
The Global Sport Utility Vehicle (SUV) Market is estimated to grow with a CAGR of ..
The global market for cosmetic bioactive ingredients is expected to advance at a C..